Anticancer drugs Flashcards
Non cell cycle specific
Alk agents
Platinum compounds
Antitumor antibiotics
Cell cycle specific
S phase inhibitors
Antimetabolites
Hydroxyurea
Topoisomerase inhibitors
Histone deacetylase inhibitors
M cycle specific
Vinca alkaloids Taxanes Epothilones Estramustine Eribulin
Mucositis
Alk agents
5fu
cytarabine
Mtx
Maximum Alopecia
Alk agents
Anthracyclines
Topoisomerase inhibitors
Dose limiting toxicity
Bone marrow suppresion
Maximum emesis
Cysplatin>carmustine>anthracyclines>high dose cyclophosphamide>dacarbazine>mechlorethamine
Minimum emesis
Chlorambucil
busulfan
bleomycin
Early onset nausea
late onste nausea
Ondansetrron
late onset-palonosetron
aprepitant fosaprepitant-nk1 antagonists
Alkylating agents
Moa
Alkyl group of AA-Binds to H atom of dna at N 7 position-mispairing of guanine-thymine->cytotoxicity
Alkylating agents most specific for which phase
G1-S phase
Mc leukemia seen in Alk agents
Mechanism of action
Duration
AML due to chromosomal deletien at 5 7
4years
Mc leukemia seen with Cisplatin
Moa
duration
AML
Duration 2-3 yrs
Topoisomerase inhibitors
Mc leukemia MOA duration
AML
translocation of mixed lineage leukemia gene 11q23
Alkylating agents Classification
Nitrogen mustards
Nitrosoureas
Methylation
Misc
Meaning of bifunctional alk agents
Two reactive groups-cause Dna cross linking-high cytotoxicity
Alk agents with one reactive group
Drugs acting via meth
- procarbazine
- dacarbazine
- temozolomide
Drugs causing crosslinking dna
Cisplatin
mitomycin c
Nitrogen mustards classification
Cyclophosphamide Ifosfamide mechlorethamine melphalan chlorambucil bendamustine
Cyclophosphamide Metaboism and MOA
Metabolised by CYP2B6- 4hydroxycyclophosphamide-aldophosphamide and chloracetaldehyde
aldophosphamide-phospharamide mustard-anticancer effect
chloroacetaldehyde-neurotoxicity
hemmorhagic cystitis
acrolein
Neoplastic uses of cyclo
Breast and ovarian cancer
solid tumors in children
non hodgkins lymphoma
non neoplastic effect of cyclo
wegwners granulomatosis
RA
Steroid dependent NS
Hemmorhagic cystitis
Ifosfamide>cyclophosphamide
Treated by
Vigorous hydration
mesna
SE of cyclophosphamide
Hemmorhagic cystitis,neurotoxicity SIADH followed by hyponatremia
Bone marrow suppresion with relative sparing of platelets
Safe in renal dysfunction
Ifosfamide
uses
CYP450
Slowly metabolised therefore toxicity is much higher
Testicular cancer-BEP regimen add on
osteosarcoma
chloroacetaldehyde causes
Neurotox-GTCS,Ataxia,coma
Most neurotoxic
Ifosfamide>cyclophosphamude
Neurotox treatment
Methylene blue
which causes vesication
Mechlorethamine
Properies of melphalan
High plasma protein binding to both albumin and alpha 1 acid glycoprotein
Multiple myeloma treatment
Induction-Lenalidomide
Bortezomib
dexamethasone ->STem cell transplantation if age <70yrs(Melphalan is contraindicated due to cytotoxicity)
MAintenance of multiple myeloma
High risk-lenalidomide+bortezomib
low risk-lenalidmide
Uses of Chlorambucil and bendamustine
CLL and hodgkins lymphoma
Classification Nitrosoureas
Carmustine
Lomustine
Somustine
Stretpozocin